A simple pill could prevent sight loss in diabetes-driven eye condition, early findings suggest

Дата публикации: 23-09-2026 18:00:38

Researchers at Trinity College Dublin, in collaboration with Breye Therapeutics, have found that an oral medication ("Danegaptide") can protect against vision-threatening damage in nonproliferative diabetic retinopathy (NPDR), a leading cause of blindness in working-age adults.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Scientists discover protein that triggers diabetic blindness	0	6.77	07-03-2026
2	Researchers develop light-activated drugs that restore sight in blind mice	5	8	15-07-2026
3	Daily eye drops could make reading glasses obsolete	6	7	15-09-2025
4	Early retinal dopamine imbalance appears across two inherited eye disease models	0	6.35	21-09-2026
5	Laser-guided nanoparticles could improve drug delivery to the back of the eye	0	7.97	20-07-2026
6	A blind retina isn't silent—and its noise may hinder efforts to restore sight	0	7.35	15-09-2026
7	Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes	0	22.68	12-06-2026
8	New experimental Alzheimer’s drug shows potential after study shows slower cognitive decline	2	6	14-07-2026
9	Efficacy and Safety of Brolucizumab for Diabetic Macular Edema	0	7.97	01-12-2023
10	Lab-grown eye cells offer fresh hope for millions at risk of blindness: Scientists say their breakthrough paves way for 'continuous supply' of retinal tissue	7	8	30-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.06. Источник: medicalxpress.com.